Efficacy and Safety of Apatinib for Elderly Patients with Advanced or Metastatic Gastric Cancer After Failure of at Least First-Line Chemotherapy: A Multi-Center, Single-Arm, Phase II Study

BACKGROUND: Apatinib improves progression-free survival and overall survival with an acceptable safety profile in Chinese patients with chemotherapy-refractory advanced or metastatic gastric cancer. However, the efficacy and safety of apatinib are unclear for elderly patients. This study was underta...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Dengfeng, Wang, Guoxiu, Zhang, Yu, Kan, Jie, Dong, Qiuxia, Zhao, Junhui, Ji, Faxiang, Li, Hao, Luo, Yushuang, Lin, Mingzhe, Li, Guoyuan, Liu, Zhibo, Ma, Xinfu, Guo, Qijing, Zhao, Fuxing, Shen, Guoshuang, Zhao, Jiuda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380789/
https://www.ncbi.nlm.nih.gov/pubmed/34434051
http://dx.doi.org/10.2147/OTT.S322710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380789/
https://www.ncbi.nlm.nih.gov/pubmed/34434051
http://dx.doi.org/10.2147/OTT.S322710

Ejemplares similares